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Numerous CpG islands containing tissue-specific differentially methylated regions 
(TDMRs) are potential methylation sites in normal cells and tissues. The VASA (also 
called DDX4) gene, is thought to be under the control of TDMRs. A total of 131 male 
patients with idiopathic azoospermia or severe oligospermia was evaluated 
histologically and screened the status of methylation of CpG islands in the VASA gene. 
Genome DNAs were obtained from testicular biopsy and modified with sodium 
bisulfite and were applied Matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS). This system is capable to analyze the 
methylated and unmethylated CpG island in genome. The methylation analysis is 
performed by an epigram as graphic data. Upon histological assessment, seventeen of 
131 patients revealed maturation arrest. Six of seventeen patients demonstrated 
particularly high VASA TDMR methylation rates, while the remaining eleven patients 
and control had low methylation rates. This study may imply VASA TDMR 
methylation is significantly higher among maturation arrest patients, in whom VASA 
gene expression was silenced. This finding represents an important contribution to the 
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Introduction 
Spermatogenesis is a complex multi-step process, mediated by different molecules, 
that encompasses the entire sequence of meiotic events from spermatogonia to mature 
spermatozoa in males. There is increasing evidence for genetic and epigenetic 
regulation of meiosis in the spermatogenesis of many model organisms. However, few 
attempts have been made at clinical investigation of this mechanism in humans. In 
particular, epigenetic changes are thought to influence male fertility 1,2. DNA 
methylation is an epigenetic modification that is related to changes in gene expression 
without accompanying changes in DNA sequence 3,4. The DNA methylation state at 
CpG dinucleotides, also known as CpG islands, is occasionally found in the promoter 
regions of many genes. CpG islands are generally not methylated during normal cell 
development, with the exception of imprinted genes and tissue-specific differentially 
methylated regions (TDMRs). Although each cell of an organism contains basically 
the same genome, gene activation is cell-specific as well as temporally and 
positionally mediated. TDMRs are hypomethylated in specific tissues and methylated 
in all other tissues 5,6, in which DNA methylation is involved in gene silencing. As a 
result, genes with hypomethylated TDMRs are expressed in a tissue-specific manner. 
Several studies have revealed that there are TDMRs at upstream regulatory regions in 
the mouse 7,8. In general, repeat sequences, promoters of tissue-specific genes, and 
gene-coding regions are hypermethylated. However, numerous CpG islands 
containing TDMRs are potential methylation sites in normal cells and tissues. 
Genome-wide epigenetic analysis recently revealed the evolutionary conservation of 
tissue-specific methylation in human brain cells, keratinocytes, and peripheral blood 
lymphocytes 9,10. 
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Furthermore, the VASA (also called DDX4) gene is thought to be under the control of 
TDMRs, Kitamura et al. found unmethylated as well as methylated CpG islands in 
human testis, since bisulphite sequencing results showed 50% of clones 
hypomethylated and 50% of clones hypermethylated11. VASA encodes a member of 
the DEAD (Asp-Glu-Ala-Asp) box family of ATP-dependent RNA helicases. This 
indicates that the methylation status of VASA promoter CpG islands with TDMs was 
associated with spermatogenesis and the regulation of VASA gene expression. 
 The VASA ortholog in Drosophila, vasa, is required for spermatogenesis and 
oogenesis by a mechanism that involves regulating the translation of mRNAs essential 
for differentiation 12. The Mouse Vasa Homolog (Mvh) gene is expressed specifically 
in the developing germ cell lineage during embryogenesis 13. It has been reported that 
male mice homozygous for a targeted mutation of Mvh exhibit a reproductive 
deficiency in which they produce no spermatozoa in the testes. Instead, premeiotic 
germ cells cease differentiation by the zygotene stage and undergo apoptotic death 14. 
In humans, the gene is mapped to human chromosome 5q; its expression is restricted 
to the testes in males, and is undetectable in somatic tissues 15. 
Moreover, VASA gene modulates RNA structure, which is a crucial step in many 
fundamental biological processes. A variety of RNA metabolic processes, including 
transcription, ribosomal biogenesis, RNA splicing, editing, and transport, and 
translational events, are also controlled by VASA 16-21. Additionally, recent studies 
have revealed VASA gene involvement in RNA metabolism and micro RNA 
processing22.  
The aim of the present study was to test the possibility that DNA methylation states in 
VASA promoter CpG islands may contribute to some forms of human idiopathic male 
infertility. In the present study, we also applied Matrix-assisted laser 
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desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis to 
identify DNA methylation states using testicular genome DNA. 
 
 
Materials and Methods 
Patients 
We recruited 131 patients with azoospermia or severe oligozoospermia (sperm 
concentration<1×106/mL), excluding abnormal karyotypes and Y chromosome 
microdeletion 23. All 131 patients underwent either open testicular biopsy or retrieval 
of sperm from testicular tissues in order to evaluate histology while attempting to 
extract testicular sperm (TESE). The Ethics Committee of Kanazawa University 
Hospital approved the study, and informed consent was obtained from all participants. 
Histological evaluation of testicular biopsies 
Testicular specimens were fixed in Bouin’s solution, and paraffin slides were 
prepared and stained by hematoxylin and eosin staining for histological evaluation. To 
diagnose the spermatogenic pattern, samples were obtained from at least three 
different (lower, middle, upper) areas in the testis. Diagnostic biopsies included 
evaluation of more than 100 sections per biopsy of seminiferous tubules per biopsy 
24,25. Testicular histology was classified into hypospermatogenesis (reduction in the 
degree of normal spermatogenic cells), maturation arrest (lack of late stage of 
spermatogenesis), Sertoli cell-only syndrome(lack of germ cells in seminiferous 
tubules), and tubular sclerosis (no germ cell or Sertoli cell present in the seminiferous 
tube) 26. 
Isolation of total RNA and genomic DNA 
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All of testicular tissue specimens from biopsy were used for isolation of total RNA 
and testicular genomic DNA. TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) was 
available for extraction of both molecules from the same specimen. Total RNA was 
treated with the TURBO DNA-free kit (Ambion, Austin, TX, USA) to remove any 
residual genomic DNA. Single-stranded cDNA was synthesized using a High-
Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). 
RT-PCR 
To define the testis-specific expression of the VASA gene, RT-PCR was performed on 
cDNA samples from normal human tissues, including testis, muscle, kidney, heart, 
brain, and colon tissues provided by Pro. Nagai, Nihon University. Taq DNA 
polymerase was used for PCR reactions (TaKaRa Bio, Shiga, Japan). PCR 
amplification for both VASA and GAPDH were performed with the following 
parameters: 95°C for 5 min; 29 cycles of denaturing at 95°C for 30 s, annealing at 
60°C for 30 s, and extention at 72°C for 30 sec; and a final incubation at 72°C for 10 
min. The PCR products were resolved on 1.2% agarose gels. Specific primer pairs 
used for VASA (NM_024415) and GAPDH (NM_002046) amplification were 5’-
CAAGAGAGGCGGCTATCGAGAT-3’ and 5’-
GTCAGAATTGCTGGTGGTGCATC-3’ (483bp) for VASA, and 5’-
GACCACAGTCCATGCCATCA-3’ and 5’-TCCACCACCCTGTTGCTGTA-3’ 
(453bp) for GAPDH. 
Confirmation of TDMR  
Kitamura et al. demonstrated that the presence of TDMRs upstream of the VASA gene 
is associated with testis-specific expression 11. The region is -1127 to -760 (368bp 
amplicon) from the transcription start site (TSS), and contains a promoter CpG island 
with 30 CpG binucleotide, a G+C content of 63.5%, and an observed/expected CpG 
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ratio of 1.01 
(http://genome.ucsc.edu/index.html?org=Human&db=hg18&hgsid=107086429). We 
analyzed this amplicon using patients’ tissue samples. 
Bisulfite treatment 
Isolated genomic DNA (1μg) from testicular specimens was converted with sodium 
bisulfite using the EZ DNA methylation kit (Zymo Research, Orange, CA, USA) 
according to the manufacturer’s instructions. 
PCR and in vitro Transcription 
The position of the VASA promoter CpG island and the amplicon analyzed in this 
study are also shown in Figure 1. Bisulfite treated DNA was subjected to PCR with 
the specific primer pair. A reverse primer of 5’-
CAGTAATACGACTCACTATAGGGAGAAGGCTCATCCACACTTTAACCAAA
AATC-3’ was tagged with a T7 promoter sequence. The forward primer used was 5’-
AGGAAGAGAGGTTTTGTATTTATAGGTTTAATAGGTTATT-3’. Amplification 
of 1μl bisulfite-treated DNA (~20 ng/μl) was performed with HotStar Taq Polymerase 
(Qiagen, Valencia, CA, USA) in a 5μl reaction volume, using PCR primers at a final 
concentration of 200 μM. PCR amplification was performed with the following 
parameters: 94°C for 15 min hot start, followed by 45 cycles of denaturing at 94°C for 
20 s, annealing at 58°C for 45 s, and extention at 72°C for 1 min, and a final 
incubation at 72°C for 3 min. After shrimp alkaline phosphatase treatment, 2μl of the 
PCR products were used as a template for in vitro transcription to obtain RNA 
transcripts. The reverse product was subjected to base-specific cleavage and the 
resulting samples were conditioned and spotted on a 384-pad SpectroCHIP® 
(Sequenom) using a MassARRAY nanodispenser®  (Samsung, Irvine, CA, USA), 
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followed by spectral acquisition on a MassARRAY Analyzer® Compact MALDI-
TOF MS (Sequenom). 
MALDI-TOF MS analysis 
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) was utilized for high-throughput quantitative DNA methylation 
assay 27. This system analyzed base-specific cleaved amplification products. In this 
study, we used the MassARRAY® Compact system (Sequenom, San Diego, CA, 
USA). The resultant methylation calls were performed by using EpiTyper software 
v1.0 (Sequenom,) to generate quantitative results per cleavage fragment (called CpG 
unit) including each CpG site or aggregate of multiple CpG sites. The graphic data 
obtained from methylation analysis using MassARRAY® was expressed as an 
epigram. 
Real-time quantitative RT-PCR 
For expression analysis of the human VASA gene, we utilized real-time quantitative 
RT-PCR. The generated sample cDNA was amplified on a LightCycler system 
(Roche Applied Science, Switzerland) using a LightCycler TaqMan Master (Roche 
Diagnostics, Mannheim, Germany). TaqMan probe was purchased from Roche 
Diagnostics. Universal probes no. 62 and no. 60 were used for VASA and GAPDH, 
respectively. Each universal probe was designed according to the Universal Probe 
Assay Design Center (https://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp). 
An additional primer pair used for VASA expression was 5’-
GGAGTTGGAAAGAGTTTTGGAA-3’ and 5’-
CAGAAACCAGAGCTATCACCATC3-’ (74bp).  The primer pair used for GAPDH 
expression was 5’-AGCCACATCGCTCAGACA-3’ and 5’-
GCCCAATACGACCAAATCC-3’ (66bp). To normalize the VASA mRNA 
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expression with respect to sample-to-sample differences in RNA input, RNA quality, 
and reverse transcriptase efficiency, we amplified the housekeeping gene GAPDH. 
We obtained the copy numbers of VASA and GAPDH according to the respective 
standard curves. The results were determined by the ratio of VASA/GAPDH in each 
cDNA sample. All PCR reactions were performed in a total volume of 20μL 
containing 4μL of 5x LightCycler TaqMan Master (Roche Diagnostics, final 
concentration: 1x), 0.3μL of 10μmol/L TaqMan probe (Roche Diagnostics, final 
concentration: 150 μmol/L), 1μL of 10μmol/L each primer (final concentration: 500 
μmol/L), 2μl of sample cDNA, and 11.6μl of DEPC-treated water. Water was used in 
the negative controls instead of cDNA template. Amplifications of VASA and GAPDH 
were performed in triplicate for each sample. The thermal cycling conditions were 10 
min at 95°C, followed by 50 cycles at 95°C for 10 s and 50 cycles at 60°C for 20 s for 
both VASA and GAPDH. The number of VASA and GAPDH transcripts in each 
sample was calculated with the LightCycler software, using these standard curves. 
Sample collection 
Several normal human tissue samples were obtained by organ donation from autopsy 
cases at the Pathology Division of the Nihon University School of Medicine in Tokyo, 
Japan. This study was approved by the Ethics Committees of both the Kanazawa 
University Graduate School of Medical Science, and the Nihon University School of 
Medicine. Informed consent was obtained from all study participants. In cases where 
tissues were received through organ donation, bereaved families or relatives provided 
informed, written consent. 
Statistical analysis 
Data were analyzed using Statistical Package for the Social Sciences statistical 
software version 11.0 (SPSS, Chicago, IL, USA).  Mann-Whitney’s U test was used 
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to compare the average methylation rate between patients within the MA and control 
groups. Welch’s t-test was used to compare VASA mRNA expression between two 
groups of maturation arrest. Studen's t-test was used to examine the correlation 
between levels of hormones.  Differences were considered as statistically significant 
at P <0.05. 
 
Results 
Patients’ characterization by histological evaluation 
Upon histological assessment, spermatogenesis was classified as normal in 39 patients. 
In the group with normal spermatogenesis, 26 patients had obstructive azoospermia, 6 
patients had retrograde ejaculation, and 7 patients presented with unknown causes. 
We defined these patients as the control group. An additional 25 patients were 
diagnosed with hypospermatogenesis. These hypospermatogenetic patients were 
excluded from this study, because testicular biopsy revealed the presence of late 
spermatogenesis and a few spermatozoa.  
Histology also revealed maturation arrest (MA) in testicular biopsy results from 17 
patients, who were defined as the MA group in this study. Although all MA patients 
lacked late spermatogenesis when examined histologically, examination of ejaculate 
revealed that some had a few spermatozoa  in the ejaculate (MA4, 8, 27), as shown in 
Tables 1 and 2. The mean ages of the control and MA groups (±SD), were 36.3±7.1 
and 35.5±5.9 years, respectively. Additionally, the remaining 50 patients had either a 
Sertoli cell only phenotype or tubular sclerosis by histologic analysis and were also 
excluded in this study because of absence of germ cells. 
VASA gene expression 
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VASA expression was detected via RT-PCR in human testicular tissues. No VASA 
expression was detected in the other five tissue types (Figure 2). Thus, the VASA gene 
was specifically expressed in testis tissue. 
Confirmation of TDMR in normal tissues  
After bisulphate treatment PCR, these amplicons were screened using MassARRAY® 
in order to evaluate the methylation status of VASA promoter CpG islands in different 
normal tissues. 
We screened normal tissues, including testis; the graphic data illustrated the 
methylation status within each amplicon (Figure 3). VASA promoter CpG islands were 
specifically hypomethylated in the testis, whereas five other tissue types were highly 
methylated.  
The evaluation of VASA TDMR methylation state in the testicular genome 
We analyzed VASA gene TDMRs (that is, VASA promoter CpG islands) using 
MassARRAY®. All samples were evaluated using testicular genome DNA. All 
controls (n=39) are hypomethylated in the TDMR of the VASA gene; the average rate 
is 16.3 ±4.83% (Figure 4). In six patients from the MA group (n=17), the methylation 
rate of each CpG unit within an amplicon is especially high; the average rate is 77.4 
±3.07%. The methylation rate was low in the remaining eleven patients, with an 
average of 29.3 ±2.68% (Figure 5). The methylation rate of the former was 
significantly higher than that of the latter (p<0.0001). It has been suggested that some 
maturation arrest might account for the methylated TDMRs in this study.   
In 25 patients from the hypospermatogenetic group, the variability of the methylation 
rate is great, the average rate is 45±21.4 %. All of the remaining 50 samples of VASA 
TDMRs are methylated; the average methylation rate of patients with Sertoli cell only 
and tubular sclerosis was 88.0 ±8.7%.  
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Expression study of methylated and unmethylated TDMRs in the MA group 
To examine the expression of the VASA gene, VASA mRNA was measured by real-
time quantitative RT-PCR. The average methylation rate and VASA gene expression 
level are depicted as a scatter plot in Figure 6a. The expression level of VASA in the 
methylated group (mean±SEM: 0.00132±0.00033) was significantly lower than in the 
remaining eleven patients (0.01391±0.00428, P = 0.0150), Figure 6b. These results 
demonstrate that highly methylated TDMRs result in low levels of gene expression. 
Thus, the alteration of methylation within the VASA promoter may greatly affect 
expression, resulting in meiotic failure. 
Clinical characteristics of patients with methylated and unmethylated TDMRs  
The general characteristics and clinical parameters of patients with the MA phenotype 
are summarized in Table 1. Methylation state is classified into two groups: high 
methylation (HM) and low methylation (LM) shown in Fig. 6a,b. In the HM group 
(n=6), all patients but one (MA4) had azoospermia in the ejaculate. In the LM group 
(n=11), all patients except two (MA8, MA15) had azoospermia in the ejaculate. 
Levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), and 
testosterone (T) in the HM group were 23.4±5.5, 7.1±2.8, and 4.6±0.7, 
respectively. In contrast, Levels of FSH, LH, and T in the LH group were 6.1±2.1, 
3.3±0.9, and 5.2±0.4, respectively. The FSH level in the HM group was 
significantly higher compared to that of the LM group (p=0.037). There was no 
significant difference in levels of LH (p=0.25) or T (p=0.52) between the HM and LM 
groups. This finding leads to the suggestion that high methylation rates in the VASA 




In this study, we identified patients with MA had a relative high methylation status, a 
reduction of VASA expression due to its promoter CpG island methylation is 
potentially responsible for the maturation arrest phenotype. 
It is well known that human VASA expression is germ cell- specific. To evaluate 
methylation status of patients’ DNA, we should collect pure population of germ cell, 
however, this is extremely difficult because of heterogeneity appearance for clinical 
samples. Therefore, we applied MALDI-TOF MS system, which was evaluated the 
rate of methylation levels in total cell population mixture, not in individual cloned 
DNA methylation. 
In this study, we confirmed moderate spermatocyte count in all 17 samples by 
histological diagnosis. To characterized the effect of methylation rate and expression 
on VASA in MA patiets, a total of 17 testicular biopsy samples were examined, six 
patients had a relative high and also indicaed a significantly lower VASA expression 
compared to the remaining eleven MA patient samples. Needless to say, the genomic 
DNA extracted from these testicular biopsy may not represent the methylation level in 
only germ cells. These testicular biopsy is contained many of somatic cells such as 
Leydig cells and Sertoli cells and so on. In extreme case of Sertoli only or tubular 
screlosis in the remaining 50 patients, VASA TDMR methylation rate indicated high as 
expected. These observations are consistent with the results obtained by Kitamura et 
al.11. Therefore, abrerrant methylation of VASA led to the molecular basis of meiotic 
arrest as one possible cause of idiopathic infertility. 
In animal experiments, Tanaka et al. generated a mutation in the mouse Vasa homolog 
gene (Mvh) and demonstrated that male knockout mice for Mvh produced no 
spermatozoa in the testes. Histological findings revealed that spermatogenesis was 
arrested in Mvh-deficient mice early in meiosis 14. Interestingly, these histological 
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findings were consistent with those observed in our six patients with histologically 
confirmed MA. Despite an apparently high level of VASA TDMR methylation, very 
few spermatozoa were present one patient in the ejacurate (MA4). Because Mvh-
deficient mice are genetically homogenous, the histology of testis may have a 
homogenous appearance. However, histology in most of testicular biopsies clinically 
is heterogenous28. 
In general, maturation arrest is clinically characterized by an absence of late 
spermatogenesis, as detected upon testicular biopsy. Testicular biopsy appears not to 
reflect the function of whole testicular areas 29, because the production of spermatozoa 
occurs in a multifocal (or “patchy”) distribution 30,31. Patients with maturation arrest 
have no or very few spermatozoa in their ejaculate. This may also imply that 
heterogeneity in testicular histology can cause heterogeneity in DNA methylation 
status of the VASA gene.  
In males, meiosis occurs by two successive divisions. In the first meiosis, primary 
spermatocytes develop into secondary spermatocytes and the second meiotic division 
yields round spermatids. Genetic regulation of meiosis during spermatogenesis 
remains unclear, although some meiotic failure is thought to result from the meiotic 
recombination frequencies 32 or the methylation state of genes’ promoter regions 1,2. 
On the one hand, ejaculate spermatozoa contain a complex of mRNAs and can now be 
assessed in a non-invasive examination of testis-specific infertility 31. It has been 
reported that the expression of VASA mRNA is significantly decreased in the ejaculate 
sperm of oligozoospermic patients33. However, the cause of the absence of VASA 
mRNA expression was not investigated in these reports. The results from this study 
demonstrate that aberrant methylation of TDMRs may be the underlying cause of 
meiotic arrest, leading to infertility. This study also may imply heterogeneous 
 13
testicular expression of VASA gene. These data raise the possibility that TDMR 
methylation in human VASA may contribute to some forms of idiopathic male 
infertility. 
In conclusion, we report the novel finding that VASA TDMR methylation is 
significantly higher among maturation arrest patients, in whom VASA gene expression 
was silenced. This finding represents an important contribution to the molecular basis 
of meiotic arrest as one possible cause of idiopathic infertility.  
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Age(yr) Semen (Spermcounts) FSH(mlU/mL) LH(mlU/mL) Testosterone(ng/mL)
MA1 31 0 13.8 1.9 3.6
MA2 26 0 36.4 9.1 7.1
MA3 44 0 25.7 7.3 2.9
MA4 33 a few* 8.5 1.6 5.8
MA5 34 0 12.4 2.8 5.8
MA6 35 0 43.33 19.83 2.78
 
Table 1   Clinical characteristics of MA patients with high methylation




Age(yr) Semen (Sperm counts) FSH(mlU/mL) LH(mlU/mL) Testosterone(ng/mL)
MA7 35 0 3.63 1.06 4.99
MA8 39 a few* 6.17 4.4 4.02
MA9 37 0 2.99 2.78 5.77
MA10 32 0 5.69 4.22 6.51
MA11 32 0 2.14 1.15 4.09
MA12 27 0 23.7 11.0 4.3
MA13 42 0 7.66 2.06 4.6
MA14 48 0 3.34 1.85 5.93
MA15 27 a few* N/A N/A N/A
MA16 31 0 2.8 1 4.11
MA17 41 0 3.4 3.29 8.15
Table 2   Clinical characteristics of MA patients with low methylation
MA; maturatin arrest N/A;not available








Fig. 1 Chromosomal location of VASA 
This map is based on the March 2006 human reference sequence (NCBI Build 36.1). 
VASA is shown as an arrow, with an arrowhead indicating the orientation of the gene. 
CpG islands are shown with the number of CpGs. The amplicon is designed from -
1127 to -760 (368bp) from the transcription start site (TSS). 
 
Figure 2. Tissue-specific expression of VASA in normal human tissues. 
cDNAs were prepared from testis, kidney, muscle, heart, brain, and pancreas. GAPDH 
was used as a positive control. 
 
Figure 3. Epigram of the VASA TDMR methylation state in normal human tissues. 
The upper ruler indicates the location of amplicon (368 bp), and the lower scale 
indicates the CpG site. Circles mark the positions of CpG sites, and dashed lines 
annotate CpG sites that could not be analyzed. The color scale in each top right corner 
indicates the methylation level. Red circles indicate that the TDMR is unmethylated. 
Gradation of circles from red to yellow indicates rates of methylation from 0% to 
100%. The epigram is shown for six normal human tissues (testis, kidney, muscle, 
heart, brain, and colon). TDMRs, tissue-specific differentially methylated regions. 
 
Figure 4. Epigram of the VASA TDMR methylation state in control patients (n=39). 
The upper ruler indicates the location of amplicon (368 bp) and the lower scale 
indicates the CpG site. Circles mark the positions of CpG sites, and dashed lines 
annotate CpG sites that could not be analyzed. The color scale in each top right corner 
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indicates the methylation level. Red circles indicate that the TDMR is unmethylated. 
Gradation of circles from red to yellow indicates rates of methylation from 0% to 
100%. 
 
Figure 5. Epigram of methylation status in TDMR of VASA in 17 patients with 
maturation arrest. 
The upper ruler indicates the location of amplicon (368 bp) and the lower scale 
indicates the CpG site. Circles mark the positions of CpG sites, and dashed lines 
annotate CpG sites that could not be analyzed. The color scale in each top right corner 
indicates the methylation level. Red circles indicate that the TDMR is unmethylated. 
Gradation of circles from red to yellow indicates rates of methylation from 0% to 
100%. 
 
Figure 6. Classfication between high and low methylated TDMRs group in patients 
with maturation arrest. 
a. Scatter plot of the methylation rate and relative expression of VASA in patients with 
maturation arrest. closed circles; low methylation of TDMR (LM) group, closed 
triangles; high methylation of TDMR (HM) group   b. The relative expression level of 
VASA between HM (n= 6) and LM group (n=11) in patients with maturation arrest. 
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